𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients

✍ Scribed by Marta Bodro; Núria Sabé; Laura Lladó; Carme Baliellas; Jordi Niubó; Jose Castellote; Joan Fabregat; Antoni Rafecas; Jordi Carratalà

Book ID
115559714
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
174 KB
Volume
18
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased incidence of cytomegalovirus i
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis
✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Valganciclovir for cytomegalovirus proph
Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
✍ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur